$ cat ./records/covax-co-founded-by-the-gates-foundation-falls-far-short-of-its-v-2021.txt
COVAX, Co-Founded by the Gates Foundation, Falls Far Short of Its Vaccine Pledge
[RECORD.TXT] · cat --full
COVAX — the global initiative to vaccinate poorer nations against COVID-19, which the Gates Foundation helped design and fund — badly missed its 2021 targets, delivering only a fraction of the two billion doses it had promised as wealthy countries bought up supply and a key Indian manufacturer halted exports. By the end of 2021, the vast majority of people in low-income countries remained unvaccinated. Critics tied the shortfall in part to the intellectual-property-protective approach championed by Gates, who had publicly resisted waiving vaccine patents. Backers said COVAX was undermined chiefly by vaccine hoarding by rich nations. The failure became a touchstone in debates over vaccine equity.
Source: https://www.statnews.com/2021/10/08/how-covax-failed-on-its-promise-to-vaccinate-the-world/
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
African Civil-Society Groups Urge the Gates Foundation to Stop Funding AGRA
Next →
Leaked IRS Files Show Bill Gates Paid a Modest Tax Rate Relative to His Wealth
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.